Sandbox:Mitra3: Difference between revisions

Revision as of 17:54, 3 August 2020

Therapuetic Considerations in RVMI

Reperfusion

Maintenance of RV preload

Decreased RV afterload

Restoring Rate/Rhythm and AV synchrony

Inotropic support

Mechanical Circulatory Support

•Thrmobolytics
•Percutaneous coronary intervention (PCI)

• Avoidance of preload reducing agents, such as:<be>

❑Nitrates

❑Diuretics

❑Morphin

• Systemic or pulmonary vasodilators:
*Inhaled nitric oxide

• In patients with bradyarrhthmias:
Atropine Pacemaker

In patients with refractory hypotension

May be needed in patients with cardiogenic shock secondary to RVMI

{{{ }}}

@@ Line 7: / Line 7: @@
 {{familytree | | | |!| | | | |!| | | | |!| | | |!| | | |!| | | |!| | | |}}
 {{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | C06 | | |
-|C01=<div style="float: left; text-align: left; width: 12em; padding:1em;"> '''Thrmobolytics''' <br> '''Percutaneous coronary intervention (PCI)''' <br>
+|C01=<div style="float: left; text-align: left; width: 12em; padding:1em;"> •'''Thrmobolytics''' <br> •'''Percutaneous coronary intervention (PCI)''' <br>
-|C02= • Avoidance of preload reducing agents, such as:<br>
+|C02= • Avoidance of preload reducing agents, such as:<be>
-❑Nitrates
+:❑Nitrates
-❑Diuretics
+:❑Diuretics
-❑Morphin|C03=• Systemic or pulmonary vasodilators:<br> *Inhaled nitric oxide<br>|C04=• In patients with bradyarrhthmias:<br> Atropine Pacemaker|C05=In patients with refractory hypotension|C06= May be needed in patients with cardiogenic shock secondary to RVMI}}
+:❑Morphin|C03=• Systemic or pulmonary vasodilators:<br> *Inhaled nitric oxide<br>|C04=• In patients with bradyarrhthmias:<br> Atropine Pacemaker|C05=In patients with refractory hypotension|C06= May be needed in patients with cardiogenic shock secondary to RVMI}}
 {{familytree | | | | | | | | | | | |!| | | |!| }}
 {{familytree/end}}